$593.31▼-2.35 (-0.39%)
Pre-Market:$593.64+0.33 (+0.06%)
United Therapeutics Corporation (UTHR)
R&D to Revenue
17.28%
Fiscal year · Period ending:

UTHR R&D to Revenue
Latest reported17.28%period ending
Latest reported17.28%period ending
UTHR FY R&D/Revenue (11000.00% → 17.28%)
Latest values, visible window
High-resolution chart · PNG
What is r&d to revenue?
R&D spending as percentage of revenue.
UTHR r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 17.2809% | |
| 16.7165% | |
| 17.5295% | |
| 16.6761% | |
| 32.0439% | |
| 24.1151% | |
| 81.6262% | |
| 21.9867% | |
| 15.3365% | |
| 9.2319% | |
| 16.7216% | |
| 18.8239% | |
| 26.7997% | |
| 18.9271% | |
| 24.2222% | |
| 27.6172% | |
| 33.0374% | |
| 84.9675% | |
| 39.514% | |
| 36.0642% | |
| 31.1021% | |
| 41.5845% | |
| 66.3973% | |
| 88.9044% | |
| 568.5953% | |
| 3,425.0323% | |
| 7,675% | |
| 11,000% |
Explore More
UTHR Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance